The novel role of pyrvinium in cancer therapy

Journal of Cellular Physiology
Amir A Momtazi-BorojeniAmirhossein Sahebkar

Abstract

Pyrvinium pamoate (PP) is a quinoline-derived cyanine dye which was officially approved by FDA for its anthelmintic properties and therapeutic function against animal-like protists such as Cryptosporidium parvum and Plasmodium falciparum in the 1950s. In the last 10 years, several studies have shown the novel activity of pyrvinium in tumor therapy. Some investigations have indicated that pyrvinium could delay or inhibit tumor cell proliferation in cancer models including colon, breast, lung and prostate cancer, and some hematological malignancies. In this review, we discuss multiple critical signaling pathways and mechanisms underlying the anticancer effects of PP. In details, pyrvinium acts through the following main mechanisms: (i) energy and autophagy depletion; and (ii) inhibition of Akt and Wnt-β-catenin-dependent pathways. Interestingly, pyrvinium has also shown potent anti-cancer stem cell activity. The overwhelming insights into the mechanism of anticancer properties of PP can help establishing novel and future anti-tumor treatment strategies.

References

Jun 1, 1976·Clinical Pharmacology and Therapeutics·T C SmithJ R Goulet
Aug 9, 1991·Science·K W KinzlerD McKechnie
Jun 30, 1984·Toxicology and Applied Pharmacology·M T Goldberg
Dec 10, 1993·Science·B RubinfeldP Polakis
Mar 1, 1996·The British Journal of Surgery·C Cunningham, M G Dunlop
Oct 6, 1997·The Journal of Biological Chemistry·K OrfordS W Byers
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·C LiuX He
Jul 29, 1999·Breast Cancer Research and Treatment·G GazitA S Lee
Apr 7, 2000·Breast Cancer Research and Treatment·P M FernandezS R Patierno
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·S Y LinM C Hung
Nov 2, 2001·Nature·T ReyaI L Weissman
Feb 9, 2002·The Journal of Biological Chemistry·Mascha van NoortHans Clevers
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward P Gelmann
Feb 1, 1962·The Journal of Pediatrics·J A TURNER, P E JOHNSON
Dec 15, 1962·British Medical Journal·A S DESAI
Sep 6, 1965·JAMA : the Journal of the American Medical Association·C C WANG, G A GALLI
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Jan 20, 2004·Trends in Cell Biology·D Thomas Rutkowski, Randal J Kaufman
Feb 3, 2004·Journal of Cellular Biochemistry·Mary-Ellen Taplin, Steven P Balk
Aug 10, 2004·Journal of Mammary Gland Biology and Neoplasia·Keith R Brennan, Anthony M C Brown
Sep 2, 2004·Journal of the National Cancer Institute·Hae-Ryong ParkKazuo Shin-ya
Nov 5, 2004·Nature·Akiko KumaNoboru Mizushima
Feb 14, 2006·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Lydia NakopoulouA Keramopoulos
Jun 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Monika KasprzyckaMariusz A Wasik
Sep 23, 2006·The New England Journal of Medicine·Craig T JordanMark Noble
Feb 24, 2007·Nature Reviews. Cancer·Kieran Harvey, Nicolas Tapon
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Felix ZeppernickChristel C Herold-Mende

❮ Previous
Next ❯

Citations

Apr 17, 2018·Journal of Cellular Physiology·Marcella BarbarinoAntonio Giordano
Jul 17, 2020·International Journal of Molecular Sciences·Federica LaudisiCarmine Stolfi
Dec 20, 2018·Medicinal Research Reviews·N G R Dayan ElshanMichael E Jung
Feb 14, 2018·Antimicrobial Agents and Chemotherapy·Lujuan GaoMing Li
Jul 3, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zonggui WangChangqing Zuo
Mar 1, 2020·Nature Communications·Xin WangTiebang Kang
Jun 14, 2019·Frontiers in Cellular and Infection Microbiology·Claudia Simm, Robin C May
Feb 22, 2021·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Shu-Wei HuangFeng-Huei Lin
Jun 7, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Bárbara CostaNuno Vale
Oct 17, 2020·Cardiovascular Research·Xuekun WuKai C Wollert
May 30, 2021·BMC Complementary Medicine and Therapies·Yitian Li
Feb 15, 2019·Organic Letters·Anastasiia A TikhomirovaR Marshall Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Related Papers

International Journal of Colorectal Disease
Armin WiegeringChristoph Otto
Clinical Pharmacology and Therapeutics
R A BuchananJ L Turner
Bulletin de la Société de pathologie exotique et de ses filiales
R CAVIER
Bulletin of the Calcutta School of Tropical Medicine
A K Bandyopadhyay, A B Chowdhury
Berliner und Münchener tierärztliche Wochenschrift
A ErnstJ Weiss
© 2022 Meta ULC. All rights reserved